A detailed history of Blackhill Capital Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Blackhill Capital Inc holds 298,230 shares of ABT stock, worth $31 Million. This represents 1.96% of its overall portfolio holdings.

Number of Shares
298,230
Previous 298,230 -0.0%
Holding current value
$31 Million
Previous $32.8 Million 3.26%
% of portfolio
1.96%
Previous 2.65%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$95.53 - $114.62 $38,212 - $45,848
-400 Reduced 0.13%
298,230 $28.9 Million
Q2 2023

Aug 11, 2023

SELL
$100.78 - $112.29 $262,028 - $291,954
-2,600 Reduced 0.86%
298,630 $32.6 Million
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $1.04 Million - $1.2 Million
-10,700 Reduced 3.43%
301,230 $29.1 Million
Q2 2022

Aug 12, 2022

SELL
$102.07 - $123.37 $224,553 - $271,414
-2,200 Reduced 0.7%
311,930 $33.9 Million
Q1 2022

May 13, 2022

SELL
$114.02 - $139.04 $912,160 - $1.11 Million
-8,000 Reduced 2.48%
314,130 $37.2 Million
Q4 2021

Feb 11, 2022

SELL
$115.53 - $141.46 $80,871 - $99,022
-700 Reduced 0.22%
322,130 $45.3 Million
Q3 2020

Nov 12, 2020

SELL
$91.64 - $111.29 $219,936 - $267,096
-2,400 Reduced 0.74%
322,830 $35.1 Million
Q2 2020

Aug 13, 2020

SELL
$76.57 - $98.0 $199,081 - $254,800
-2,600 Reduced 0.79%
325,230 $29.7 Million
Q1 2020

May 12, 2020

SELL
$62.82 - $91.86 $113,076 - $165,348
-1,800 Reduced 0.55%
327,830 $25.9 Million
Q4 2019

Feb 10, 2020

SELL
$78.51 - $87.4 $290,487 - $323,380
-3,700 Reduced 1.11%
329,630 $28.6 Million
Q3 2019

Nov 07, 2019

SELL
$81.84 - $88.74 $417,384 - $452,574
-5,100 Reduced 1.51%
333,330 $27.9 Million
Q2 2019

Jul 29, 2019

SELL
$72.88 - $85.0 $728,800 - $850,000
-10,000 Reduced 2.87%
338,430 $28.5 Million
Q4 2018

Jan 31, 2019

SELL
$65.56 - $74.27 $287,152 - $325,302
-4,380 Reduced 1.24%
348,430 $25.2 Million
Q2 2018

Aug 06, 2018

SELL
$57.57 - $63.54 $708,111 - $781,542
-12,300 Reduced 3.37%
352,810 $21.5 Million
Q1 2018

May 08, 2018

SELL
$56.27 - $63.62 $326,366 - $368,996
-5,800 Reduced 1.56%
365,110 $21.9 Million
Q4 2017

Feb 05, 2018

SELL
$53.68 - $57.47 $429,440 - $459,760
-8,000 Reduced 2.11%
370,910 $21.2 Million
Q3 2017

Nov 02, 2017

BUY
$48.06 - $53.64 $18.2 Million - $20.3 Million
378,910
378,910 $20.2 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $182B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Blackhill Capital Inc Portfolio

Follow Blackhill Capital Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blackhill Capital Inc, based on Form 13F filings with the SEC.

News

Stay updated on Blackhill Capital Inc with notifications on news.